Skip to main content

Advertisement

Log in

Prognostic impact of Metadherin–SND1 interaction in colon cancer

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

The interaction between Metadherin (MTDH) and Staphylococcal nuclease homology domain containing 1 (SND1) is involved in tumorigenesis and tumor progression of several human malignancies. However, its roles in colon cancer are still unclear. To investigate the clinical value of MTDH and SND1 expression in colon cancer. Immunohistochemical staining was performed to detect the expression of MTDH and SND1 using human colon cancer and their corresponding non-cancerous colon tissues from 196 patients’ biopsies. Positive expression of MTDH and SND1 were both increased in colon cancer tissues compared to paired non-cancerous colon tissues. There was a positive correlation between MTDH and SND1 expression in colon cancer tissues (r = 0.86, p < 0.001). In addition, their positive expression were both significantly associated with nodal status (both p = 0.02), pathological stage (p = 0.006 and 0.008, respectively) and differentiation (both p = 0.03). Moreover, the overall survival in colon cancer patients with positive expression of MTDH and SND1 were significantly shorter than those without their expression (both p = 0.01). Furthermore, multivariate Cox regression analysis suggested that positive expression of MTDH and SND1 was an independent poor prognostic predictor in colon cancer. Our data suggest that the increased expression of MTDH and/or SND1 is closely related to carcinogenesis, progression, and prognosis of colon cancer. The co-expression of MTDH/SND1 may be a novel distinctive marker to benefit us in prediction of the prognosis in colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Neumann J, Bahr F, Horst D, Kriegl L, Engel J, Luque RM, Gerhard M, Kirchner T, Jung A (2011) SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11:518

    Article  PubMed  Google Scholar 

  2. Beji A, Horst D, Engel J, Kirchner T, Ullrich A (2012) Toward the prognostic significance and therapeutic potential of HER3 receptor tyrosine kinase in human colon cancer. Clin Cancer Res 18:956–968

    Article  PubMed  CAS  Google Scholar 

  3. Gulubova MV, Ananiev JR, Vlaykova TI, Yovchev Y, Tsoneva V, Manolova IM (2012) Role of dendritic cells in progression and clinical outcome of colon cancer. Int J Colorectal Dis 27:159–169

    Article  PubMed  Google Scholar 

  4. Kong X, Moran MS, Zhao Y, Yang Q (2012) Inhibition of metadherin sensitizes breast cancer cells to AZD6244. Cancer Biol Ther 13:43–49

    Article  PubMed  CAS  Google Scholar 

  5. Zhao Y, Kong X, Li X, Yan S, Yuan C, Hu W, Yang Q (2011) Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS ONE 6:e29363

    Article  PubMed  CAS  Google Scholar 

  6. Hui AB, Bruce JP, Alajez NM, Shi W, Yue S, Perez-Ordonez B, Xu W, O’Sullivan B, Waldron J, Cummings B, Gullane P, Siu L, Liu FF (2011) Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin Cancer Res 17:7539–7550

    Article  PubMed  CAS  Google Scholar 

  7. Brown DM, Ruoslahti E (2004) Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. Cancer Cell 5:365–374

    Article  PubMed  CAS  Google Scholar 

  8. Yu C, Chen K, Zheng H, Guo X, Jia W, Li M, Zeng M, Li J, Song L (2009) Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30:894–901

    Article  PubMed  CAS  Google Scholar 

  9. Zhao Y, Moran MS, Yang Q, Liu Q, Yuan C, Hong S, Kong B (2012) Metadherin regulates radioresistance in cervical cancer cells. Oncol Rep 27(5):1520–1526. doi:10.3892/or.2012.1692

    PubMed  CAS  Google Scholar 

  10. Meng F, Luo C, Ma L, Hu Y, Lou G (2011) Clinical significance of astrocyte elevated gene-1 expression in human epithelial ovarian carcinoma. Int J Gynecol Pathol 30:145–150

    Article  PubMed  Google Scholar 

  11. Li X, Kong X, Huo Q, Guo H, Yan S, Yuan C, Moran MS, Shao C, Yang Q (2011) Metadherin enhances the invasiveness of breast cancer cells by inducing epithelial to mesenchymal transition. Cancer Sci 102:1151–1157

    Article  PubMed  CAS  Google Scholar 

  12. Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J, Zhou J (2011) Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res 17:7294–7302

    Article  PubMed  CAS  Google Scholar 

  13. Li C, Li Y, Wang X, Wang Z, Cai J, Wang L, Zhao Y, Song H, Meng X, Ning X, Xu C, Lin M, Li L, Geng J (2012) Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III–IV serous ovarian carcinoma. Histopathology 60(6):953–963. doi:10.1111/j.1365-2559.2012.04182.x

    Article  PubMed  Google Scholar 

  14. Sun S, Ke Z, Wang F, Li S, Chen W, Han A, Wang Z, Shi H, Wang LT, Chen X (2011) Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression. Hum Pathol 43(7):1051–1060

    Article  PubMed  Google Scholar 

  15. Song H, Li C, Lu R, Zhang Y, Geng J (2010) Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer. Int J Gynecol Cancer. 20:1188–1196

    Article  PubMed  Google Scholar 

  16. Ying Z, Li J, Li M (2011) Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond. Cell Biosci 1:36

    Article  PubMed  CAS  Google Scholar 

  17. Liu K, Chen C, Guo Y, Lam R, Bian C, Xu C, Zhao DY, Jin J, MacKenzie F, Pawson T, Min J (2010) Structural basis for recognition of arginine methylated Piwi proteins by the extended Tudor domain. Proc Natl Acad Sci USA 107:18398–18403

    Article  PubMed  CAS  Google Scholar 

  18. Hossain MJ, Korde R, Singh PK, Kanodia S, Ranjan R, Ram G, Kalsey GS, Singh R, Malhotra P (2010) Plasmodium falciparum Tudor Staphylococcal Nuclease interacting proteins suggest its role in nuclear as well as splicing processes. Gene 468:48–57

    Article  PubMed  CAS  Google Scholar 

  19. Tsuchiya N, Nakagama H (2010) MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis. Mutat Res 693:94–100

    Article  PubMed  CAS  Google Scholar 

  20. Kuruma H, Kamata Y, Takahashi H, Igarashi K, Kimura T, Miki K, Miki J, Sasaki H, Hayashi N, Egawa S (2009) Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer. Am J Pathol 174:2044–2050

    Article  PubMed  CAS  Google Scholar 

  21. Yoo BK, Santhekadur PK, Gredler R, Chen D, Emdad L, Bhutia S, Pannell L, Fisher PB, Sarkar D (2011) Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 53:1538–1548

    Article  PubMed  CAS  Google Scholar 

  22. Blanco MA, Aleckovi M, Hua Y, Li T, Wei Y, Xu Z, Cristea IM, Kang Y (2011) Identification of staphylococcal nuclease domain-containing 1 (SND1) as a Metadherin-interacting protein with metastasis-promoting functions. J Biol Chem 286:19982–19992

    Article  PubMed  CAS  Google Scholar 

  23. Liu DC, Yang ZL (2011) MTDH and EphA7 are markers for metastasis and poor prognosis of gallbladder adenocarcinoma. Diagn Cytopathol. doi:10.1002/dc.21821

    Google Scholar 

  24. Hu G, Wei Y, Kang Y (2009) The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 15:5615–5620

    Article  PubMed  CAS  Google Scholar 

  25. Yoo BK, Emdad L, Lee SG, Su ZZ, Santhekadur P, Chen D, Gredler R, Fisher PB, Sarkar D (2011) Astrocyte elevated gene-1 (AEG-1): a multifunctional regulator of normal and abnormal physiology. Pharmacol Ther 130:1–8

    Article  PubMed  CAS  Google Scholar 

  26. Bhutia SK, Kegelman TP, Das SK, Azab B, Su ZZ, Lee SG, Sarkar D, Fisher PB (2011) Astrocyte elevated gene-1 activates AMPK in response to cellular metabolic stress and promotes protective autophagy. Autophagy 7:547–548

    Article  PubMed  Google Scholar 

  27. Yang J, Aittomaki S, Pesu M, Carter K, Saarinen J, Kalkkinen N, Kieff E, Silvennoinen O (2002) Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. EMBO J 21:4950–4958

    Article  PubMed  CAS  Google Scholar 

  28. Caudy AA, Ketting RF, Hammond SM, Denli AM, Bathoorn AM, Tops BB, Silva JM, Myers MM, Hannon GJ, Plasterk RH (2003) A micrococcal nuclease homologue in RNAi effector complexes. Nature 425:411–414

    Article  PubMed  CAS  Google Scholar 

  29. Tsuchiya N, Ochiai M, Nakashima K, Ubagai T, Sugimura T, Nakagama H (2007) SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis. Cancer Res 67:9568–9576

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81172287 and No.81200330).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xianli He or Jianguo Lu.

Additional information

Nan-Wang and Xilin-Du equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, N., Du, X., Zang, L. et al. Prognostic impact of Metadherin–SND1 interaction in colon cancer. Mol Biol Rep 39, 10497–10504 (2012). https://doi.org/10.1007/s11033-012-1933-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1933-0

Keywords

Navigation